The National Heart, Lung, and Blood Institute (NHLBI) awarded a $827,187 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Ocean State Research Institute Inc., a non-profit organization, to investigate the mechanisms underlying impaired right ventricular mitochondrial energetics and function in pulmonary hypertension. The funding period for this project runs from May 1, 2024 to February 29, 2028. The research aims to delineate the role of mitochondrial c-Src in right ventricular dysfunction in pulmonary hypertension, with the goal of identifying new targeted strategies to preserve and restore electron transport chain function in right ventricular cardiomyocytes. As a sub-awardee, Ocean State Research Institute has partnered with universities to participate in various clinical trials and contribute to veterans' health research programs.
Generated 3/4/25, 7:12 AM